Funding
Series B · Biotech

Kuehnle AgroSystems secures Series B financing

Ichthus Venture Capital, S2G Investments, Hatch Blue and Dest EOOD participated in the financing.

Updated Oct 16, 2026By RoundOS Funding desk

Kuehnle AgroSystems secured Series B financing on July 8. Participants included Ichthus Venture Capital, S2G Investments, Hatch Blue and Dest EOOD. The amount was not disclosed. The company develops microalgal ingredients using dark fermentation.

Funding history

Series B · This roundUndisclosed

Sources

  1. Kuehnle AgroSystemsprojectstartups.com
  2. businesswire.com

Similar rounds

All Biotech rounds →
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Warp Sciences

Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.

$215MSeries A · Oct 22, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026

Related